JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Malmberg, A. B.
Right arrow Articles by Yaksh, T. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Malmberg, A. B.
Right arrow Articles by Yaksh, T. L.

Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat

AB Malmberg and TL Yaksh

Department of Anesthesiology, University of California, San Diego, La Jolla.

Subcutaneous injection of formalin into the dorsal surface of the hindpaw evoked a two-phased flinching (phase 1:0-9 min; phase 2: 10-60 min) of the injected paw. Intrathecal administration of the nonsteroidal anti-inflammatory drugs (NSAID) produced minimal effects upon phase 1, but showed a significant, though submaximal, dose- dependent suppression of the phase 2 response. Ordering of i.t. potency was (ID50 in nmol): indomethacin (1.9) > or = flurbiprofen (2.1) > ketorolac (5.2) > or = zomepirac (5.9) > S(+)ibuprofen (16) > or = ibuprofen(racemic) (19) > acetylsalicylic acid (27) > acetaminophen (250) > R(-)ibuprofen (> 270) = 0. Intraperitoneal administration also produced a dose-dependent inhibition of phase 2, but only at doses which were 100 to 1000 times higher than those required to produce similar effects after i.t. injection. Intrathecal and i.p. dose- response curves showed similar distinct plateaus of maximum achievable inhibition (intrinsic activity) of the phase 2 behavior, ranging from 20 to 50% of the control response. Varying the time of drug injection reveals that injection 9 min after formalin yielded effects the same as those observed when the agent was given 2 min before formalin. Pretreatment at longer intervals indicated that the duration of the antinociceptive effect was between 3 to 6 hr after the i.t. injection. The i.t. injection of the highest doses of the several NSAID were without significant effect upon the 52.5 degrees C hot plate test. These studies indicate that NSAID have a powerful effect upon spinal nociceptive processing evoked by the s.c. injection of formalin.

Volume 263, Issue 1, pp. 136-146, 10/01/1992
Copyright © 1992 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J Clin PharmacolHome page
E. Kumpulainen, H. Kokki, M. Laisalmi, M. Heikkinen, J. Savolainen, J. Rautio, and M. Lehtonen
How Readily Does Ketorolac Penetrate Cerebrospinal Fluid in Children?
J. Clin. Pharmacol., April 1, 2008; 48(4): 495 - 501.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
H. Kokki, E. Kumpulainen, M. Lehtonen, M. Laisalmi, M. Heikkinen, J. Savolainen, and J. Rautio
Cerebrospinal Fluid Distribution of Ibuprofen After Intravenous Administration in Children
Pediatrics, October 1, 2007; 120(4): e1002 - e1008.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. R. McNamara, J. Mandel-Brehm, D. M. Bautista, J. Siemens, K. L. Deranian, M. Zhao, N. J. Hayward, J. A. Chong, D. Julius, M. M. Moran, et al.
TRPA1 mediates formalin-induced pain
PNAS, August 14, 2007; 104(33): 13525 - 13530.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. Bonnefont, L. Daulhac, M. Etienne, E. Chapuy, C. Mallet, L. Ouchchane, C. Deval, J.-P. Courade, M. Ferrara, A. Eschalier, et al.
Acetaminophen Recruits Spinal p42/p44 MAPKs and GH/IGF-1 Receptors to Produce Analgesia via the Serotonergic System
Mol. Pharmacol., February 1, 2007; 71(2): 407 - 415.
[Abstract] [Full Text] [PDF]


Home page
J Clin PharmacolHome page
A. Mannila, E. Kumpulainen, M. Lehtonen, M. Heikkinen, M. Laisalmi, T. Salo, J. Rautio, J. Savolainen, and H. Kokki
Plasma and Cerebrospinal Fluid Concentrations of Indomethacin in Children After Intravenous Administration
J. Clin. Pharmacol., January 1, 2007; 47(1): 94 - 100.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
U. Guevara-Lopez, A. Covarrubias-Gomez, H. Gutierrez-Acar, J. A. Aldrete, F. J. Lopez-Munoz, and B. Martinez-Benitez
Chronic Subarachnoid Administration of 1-(4chlorobenzoyl)-5methoxy-2methyl-1H-indole-3 Acetic Acid (Indomethacin): An Evaluation of Its Neurotoxic Effects in an Animal Model.
Anesth. Analg., July 1, 2006; 103(1): 99 - 102.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. Roy, X. Guo, J. Kelschenbach, Y. Liu, and H. H. Loh
In Vivo Activation of a Mutant {micro}-Opioid Receptor by Naltrexone Produces a Potent Analgesic Effect But No Tolerance: Role of {micro}-Receptor Activation and {delta}-Receptor Blockade in Morphine Tolerance
J. Neurosci., March 23, 2005; 25(12): 3229 - 3233.
[Abstract] [Full Text] [PDF]


Home page
J Clin PharmacolHome page
R. A. Dionne, D. Haynes, J. S. Brahim, J. S. Rowan, and P.-H. Guivarc'h
Analgesic Effect of Sustained-Release Flurbiprofen Administered at the Site of Tissue Injury in the Oral Surgery Model
J. Clin. Pharmacol., December 1, 2004; 44(12): 1418 - 1424.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
M.-A. Docquier, P. Lavand'homme, V. Boulanger, V. Collet, and M. De Kock
Questioning the cardiocirculatory excitatory effects of opioids under volatile anaesthesia
Br. J. Anaesth., September 1, 2004; 93(3): 408 - 413.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
T. L. Yaksh, K. A. Horais, N. Tozier, M. Rathbun, P. Richter, S. Rossi, M. Grafe, C. Tong, C. Meschter, J. M. Cline, et al.
Intrathecal Ketorolac in Dogs and Rats
Toxicol. Sci., August 1, 2004; 80(2): 322 - 334.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
L. Shi, P. Lebrun, F. Camu, and M. Zizi
Intrathecal Catheterization and Solvents Interfere with Cortical Somatosensory Evoked Potentials Used in Assessing Nociception in Awake Rats
Anesth. Analg., July 1, 2004; 99(1): 159 - 165.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
X.-Y. Hua, C. S. Hayes, A. Hofer, B. Fitzsimmons, K. Kilk, U. Langel, T. Bartfai, and T. L. Yaksh
Galanin Acts at GalR1 Receptors in Spinal Antinociception: Synergy with Morphine and AP-5
J. Pharmacol. Exp. Ther., February 1, 2004; 308(2): 574 - 582.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
H. A. Korkmaz, F. Maltepe, S. Erbayraktar, O. Yilmaz, M. Guray, M. S. Canda, A. Gunerli, and N. Gokmen
Antinociceptive and Neurotoxicologic Screening of Chronic Intrathecal Administration of Ketorolac Tromethamine in the Rat
Anesth. Analg., January 1, 2004; 98(1): 148 - 152.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
A. Bonabello, M. R. Galmozzi, R. Canaparo, G. C. Isaia, L. Serpe, E. Muntoni, and G. P. Zara
Dexibuprofen (S(+)-Isomer Ibuprofen) Reduces Gastric Damage and Improves Analgesic and Antiinflammatory Effects in Rodents
Anesth. Analg., August 1, 2003; 97(2): 402 - 408.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K.-i. Hayashida, T. Takeuchi, H. Shimizu, K. Ando, and E. Harada
Lactoferrin enhances opioid-mediated analgesia via nitric oxide in the rat spinal cord
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2003; 285(2): R306 - R312.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
J. A. Aldrete
Epidural Injections of Indomethacin for Postlaminectomy Syndrome: A Preliminary Report
Anesth. Analg., February 1, 2003; 96(2): 463 - 468.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. A. C. Sabino, J. R. Ghilardi, J. L. M. Jongen, C. P. Keyser, N. M. Luger, D. B. Mach, C. M. Peters, S. D. Rogers, M. J. Schwei, C. de Felipe, et al.
Simultaneous Reduction in Cancer Pain, Bone Destruction, and Tumor Growth by Selective Inhibition of Cyclooxygenase-2
Cancer Res., December 15, 2002; 62(24): 7343 - 7349.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. D. Freshwater, C. I. Svensson, A. B. Malmberg, and N. A. Calcutt
Elevated Spinal Cyclooxygenase and Prostaglandin Release During Hyperalgesia in Diabetic Rats
Diabetes, July 1, 2002; 51(7): 2249 - 2255.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
T. Yamamoto and N. Nozaki-Taguchi
The Role of Cyclooxygenase-1 and -2 in the Rat Formalin Test
Anesth. Analg., April 1, 2002; 94(4): 962 - 967.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
D. Le Bars, M. Gozariu, and S. W. Cadden
Animal Models of Nociception
Pharmacol. Rev., December 1, 2001; 53(4): 597 - 652.
[Abstract] [Full Text] [PDF]


Home page
Canadian J. AnesthesiaHome page
D. J. Kelly, M. Ahmad, and S. J. Brull
Preemptive analgesia I: physiological pathways and pharmacological modalities : [L'analgesie preventive I : mecanismes physiologiques et modalites pharmacologiques]
Can J Anesth, November 1, 2001; 48(10): 1000 - 1010.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
B. Milne, S. R. Hall, M. E. Sullivan, and C. Loomis
The Release of Spinal Prostaglandin E2 and the Effect of Nitric Oxide Synthetase Inhibition During Strychnine-Induced Allodynia
Anesth. Analg., September 1, 2001; 93(3): 728 - 733.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
T. L. Yaksh, D. M. Dirig, C. M. Conway, C. Svensson, Z. D. Luo, and P. C. Isakson
The Acute Antihyperalgesic Action of Nonsteroidal, Anti-Inflammatory Drugs and Release of Spinal Prostaglandin E2 Is Mediated by the Inhibition of Constitutive Spinal Cyclooxygenase-2 (COX-2) but not COX-1
J. Neurosci., August 15, 2001; 21(16): 5847 - 5853.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
B. L. Kidd and L. A. Urban
Mechanisms of inflammatory pain
Br. J. Anaesth., July 1, 2001; 87(1): 3 - 11.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
T. L. Yaksh, G. Ozaki, D. McCumber, M. Rathbun, C. Svensson, S. Malkmus, and M. C. Yaksh
An automated flinch detecting system for use in the formalin nociceptive bioassay
J Appl Physiol, June 1, 2001; 90(6): 2386 - 2402.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
H. Baba, T. Kohno, K. A. Moore, and C. J. Woolf
Direct Activation of Rat Spinal Dorsal Horn Neurons by Prostaglandin E2
J. Neurosci., March 1, 2001; 21(5): 1750 - 1756.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
D McCarthy
Prostaglandins, COX-2, and sensory perception
Gut, December 1, 2000; 47(90004): iv66 - 68.
[Full Text] [PDF]


Home page
Br J AnaesthHome page
C. -S. Wong, M. -M. Hsu, R. Chou, Y. -Y. Chou, and C. -S. Tung
Intrathecal cyclooxygenase inhibitor administration attenuates morphine antinociceptive tolerance in rats
Br. J. Anaesth., November 1, 2000; 85(5): 747 - 751.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
S. A. Dunbar, I. G. Karamov, and H. Buerkle
The Effect of Spinal Ibuprofen on Opioid Withdrawal in the Rat
Anesth. Analg., August 1, 2000; 91(2): 417 - 422.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
T. Nishiyama, L. Gyermek, C. Lee, S. Kawasaki-Yatsugi, and T. Yamaguchi
The Systemically Administered Competitive AMPA Receptor Antagonist, YM872, has Analgesic Effects on Thermal or Formalin-Induced Pain in Rats
Anesth. Analg., December 1, 1999; 89(6): 1534 - 1534.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
T. Nishiyama, L. Gyermek, C. Lee, S. Kawasaki-Yatsugi, and T. Yamaguchi
The Spinal Antinociceptive Effects of a Novel Competitive AMPA Receptor Antagonist, YM872, on Thermal or Formalin-Induced Pain in Rats
Anesth. Analg., July 1, 1999; 89(1): 143 - 143.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
K. E. Tighe, A. M. Webb, and G. J. Hobbs
Persistently High Plasma Morphine-6-Glucuronide Levels Despite Decreased Hourly Patient-Controlled Analgesia Morphine Use After Single-Dose Diclofenac: Potential for Opioid-Related Toxicity
Anesth. Analg., May 1, 1999; 88(5): 1137 - 1142.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. R. S. Santos, O. G. Miguel, R. A. Yunes, and J. B. Calixto
Antinociceptive Properties of the New Alkaloid, cis-8,10-Di-N-Propyllobelidiol Hydrochloride Dihydrate Isolated from Siphocampylus verticillatus: Evidence for the Mechanism of Action
J. Pharmacol. Exp. Ther., April 1, 1999; 289(1): 417 - 426.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
M.-F. Jett, C. S. Ramesha, C. D. Brown, S. Chiu, C. Emmett, T. Voronin, T. Sun, C. O'Yang, J. C. Hunter, R. M. Eglen, et al.
Characterization of the Analgesic and Anti-Inflammatory Activities of Ketorolac and Its Enantiomers in the Rat
J. Pharmacol. Exp. Ther., March 1, 1999; 288(3): 1288 - 1297.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. J. Smith, Y. Zhang, C. M. Koboldt, J. Muhammad, B. S. Zweifel, A. Shaffer, J. J. Talley, J. L. Masferrer, K. Seibert, and P. C. Isakson
Pharmacological analysis of cyclooxygenase-1 in inflammation
PNAS, October 27, 1998; 95(22): 13313 - 13318.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Zhang, A. Shaffer, J. Portanova, K. Seibert, and P. C. Isakson
Inhibition of Cyclooxygenase-2 Rapidly Reverses Inflammatory Hyperalgesia and Prostaglandin E2 Production
J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1069 - 1075.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
D. Bustamante, C. Paeile, J.-C. Willer, and D. Le Bars

J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1381 - 1391.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
S. R. Chaplan, A. B. Malmberg, and T. L. Yaksh
Efficacy of Spinal NMDA Receptor Antagonism in Formalin Hyperalgesia and Nerve Injury Evoked Allodynia in the Rat
J. Pharmacol. Exp. Ther., February 1, 1997; 280(2): 829 - 838.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
L. A. Pini, G. Vitale, A. Ottani, and M. Sandrini
Naloxone-Reversible Antinociception by Paracetamol in the Rat
J. Pharmacol. Exp. Ther., February 1, 1997; 280(2): 934 - 940.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1992 by the American Society for Pharmacology and Experimental Therapeutics.